Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
MicroRNAs | 14 | 2024 | 3783 | 2.040 |
Why?
|
RNA, Small Interfering | 11 | 2019 | 3432 | 1.570 |
Why?
|
Nanoparticles | 12 | 2017 | 1940 | 1.350 |
Why?
|
Islets of Langerhans Transplantation | 10 | 2015 | 738 | 1.240 |
Why?
|
Islets of Langerhans | 12 | 2017 | 1345 | 1.160 |
Why?
|
Doxorubicin | 5 | 2017 | 2209 | 1.140 |
Why?
|
Molecular Imaging | 6 | 2017 | 815 | 1.120 |
Why?
|
Oligonucleotides | 3 | 2020 | 582 | 1.020 |
Why?
|
Carbocyanines | 6 | 2024 | 175 | 0.960 |
Why?
|
Magnetic Resonance Imaging | 26 | 2024 | 36284 | 0.770 |
Why?
|
Ferric Compounds | 5 | 2016 | 377 | 0.750 |
Why?
|
RNA Interference | 5 | 2021 | 2836 | 0.750 |
Why?
|
Magnetite Nanoparticles | 5 | 2019 | 315 | 0.710 |
Why?
|
Diabetes Mellitus, Experimental | 5 | 2017 | 1111 | 0.690 |
Why?
|
Cell Line, Tumor | 21 | 2024 | 16886 | 0.680 |
Why?
|
Pancreas | 5 | 2019 | 1676 | 0.660 |
Why?
|
Mammary Neoplasms, Animal | 1 | 2019 | 124 | 0.630 |
Why?
|
Biosensing Techniques | 2 | 2016 | 649 | 0.630 |
Why?
|
Breast Neoplasms | 13 | 2024 | 21017 | 0.570 |
Why?
|
Antimetabolites, Antineoplastic | 2 | 2019 | 638 | 0.550 |
Why?
|
Mucin-1 | 6 | 2016 | 539 | 0.540 |
Why?
|
Drug Carriers | 2 | 2019 | 705 | 0.530 |
Why?
|
Neoplastic Stem Cells | 2 | 2024 | 1346 | 0.520 |
Why?
|
RNA-Induced Silencing Complex | 1 | 2016 | 56 | 0.520 |
Why?
|
Inhibitor of Apoptosis Proteins | 2 | 2013 | 197 | 0.500 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2019 | 730 | 0.480 |
Why?
|
Spectroscopy, Near-Infrared | 4 | 2009 | 739 | 0.480 |
Why?
|
Mice | 45 | 2024 | 81101 | 0.470 |
Why?
|
Chickens | 3 | 2015 | 860 | 0.470 |
Why?
|
Molecular Targeted Therapy | 2 | 2017 | 2796 | 0.460 |
Why?
|
Microscopy, Fluorescence | 9 | 2016 | 2646 | 0.440 |
Why?
|
Nanocapsules | 1 | 2014 | 92 | 0.430 |
Why?
|
Xenograft Model Antitumor Assays | 7 | 2024 | 3574 | 0.420 |
Why?
|
Cell Movement | 4 | 2024 | 5201 | 0.420 |
Why?
|
Adenocarcinoma | 5 | 2013 | 6313 | 0.390 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2015 | 675 | 0.390 |
Why?
|
Magnetics | 2 | 2012 | 600 | 0.380 |
Why?
|
Animals | 52 | 2024 | 167768 | 0.380 |
Why?
|
Neoplasms, Experimental | 2 | 2014 | 1228 | 0.370 |
Why?
|
Subrenal Capsule Assay | 1 | 2009 | 27 | 0.340 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2024 | 8506 | 0.340 |
Why?
|
Pancreatic Neoplasms | 4 | 2019 | 5349 | 0.330 |
Why?
|
Oxides | 3 | 2009 | 401 | 0.320 |
Why?
|
Diabetes Mellitus, Type 1 | 7 | 2010 | 3432 | 0.320 |
Why?
|
Spectrum Analysis, Raman | 1 | 2010 | 237 | 0.320 |
Why?
|
Drug Delivery Systems | 5 | 2017 | 2212 | 0.310 |
Why?
|
Neoplasm Metastasis | 5 | 2024 | 4901 | 0.310 |
Why?
|
Brain Neoplasms | 5 | 2024 | 8981 | 0.300 |
Why?
|
Disease Models, Animal | 11 | 2024 | 18119 | 0.300 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2019 | 1724 | 0.300 |
Why?
|
Isoantigens | 2 | 2015 | 552 | 0.290 |
Why?
|
Metal Nanoparticles | 1 | 2012 | 396 | 0.290 |
Why?
|
Neoplasms | 7 | 2020 | 22032 | 0.290 |
Why?
|
Iron | 5 | 2014 | 1786 | 0.270 |
Why?
|
Gene Expression | 2 | 2016 | 7583 | 0.260 |
Why?
|
Zinc | 1 | 2010 | 687 | 0.260 |
Why?
|
Apoptosis | 6 | 2019 | 9468 | 0.260 |
Why?
|
Nanostructures | 1 | 2010 | 547 | 0.260 |
Why?
|
Insulin-Secreting Cells | 2 | 2011 | 896 | 0.260 |
Why?
|
Microtubule-Associated Proteins | 1 | 2010 | 1074 | 0.250 |
Why?
|
Dextrans | 5 | 2024 | 573 | 0.240 |
Why?
|
Transplantation, Autologous | 1 | 2009 | 2114 | 0.230 |
Why?
|
Cell Proliferation | 5 | 2024 | 10416 | 0.230 |
Why?
|
Eimeria tenella | 1 | 2003 | 3 | 0.230 |
Why?
|
Coccidiosis | 1 | 2003 | 10 | 0.220 |
Why?
|
Poultry Diseases | 1 | 2003 | 26 | 0.220 |
Why?
|
Cecal Diseases | 1 | 2003 | 49 | 0.220 |
Why?
|
Mice, Nude | 6 | 2016 | 3602 | 0.220 |
Why?
|
Peptides | 6 | 2012 | 4341 | 0.220 |
Why?
|
Immunotherapy | 1 | 2019 | 4641 | 0.220 |
Why?
|
Mucins | 1 | 2006 | 568 | 0.210 |
Why?
|
Sarcoma, Avian | 1 | 2002 | 3 | 0.210 |
Why?
|
Microcirculation | 1 | 2007 | 1273 | 0.210 |
Why?
|
Oligonucleotides, Antisense | 3 | 2024 | 459 | 0.200 |
Why?
|
Fluorescence | 3 | 2017 | 749 | 0.190 |
Why?
|
Gene Silencing | 2 | 2010 | 1507 | 0.190 |
Why?
|
Staining and Labeling | 1 | 2006 | 1083 | 0.190 |
Why?
|
Contrast Media | 8 | 2016 | 5298 | 0.190 |
Why?
|
Histocompatibility Antigens | 1 | 2002 | 467 | 0.180 |
Why?
|
Fluorescent Dyes | 5 | 2017 | 1897 | 0.180 |
Why?
|
Hyperglycemia | 2 | 2008 | 1368 | 0.180 |
Why?
|
Models, Biological | 1 | 2017 | 9460 | 0.180 |
Why?
|
Cell Survival | 3 | 2020 | 5781 | 0.180 |
Why?
|
Gadolinium | 3 | 2012 | 959 | 0.180 |
Why?
|
Mammary Neoplasms, Experimental | 2 | 2024 | 507 | 0.180 |
Why?
|
Fluorescein-5-isothiocyanate | 2 | 2011 | 222 | 0.170 |
Why?
|
Diagnostic Imaging | 3 | 2009 | 3526 | 0.160 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 11709 | 0.160 |
Why?
|
Drug Resistance, Multiple | 1 | 2020 | 253 | 0.160 |
Why?
|
Gadolinium DTPA | 2 | 2012 | 823 | 0.160 |
Why?
|
Mice, Inbred BALB C | 4 | 2019 | 6209 | 0.160 |
Why?
|
Female | 28 | 2024 | 390323 | 0.150 |
Why?
|
Molecular Probes | 3 | 2009 | 310 | 0.150 |
Why?
|
Neoplasm Invasiveness | 2 | 2019 | 3617 | 0.150 |
Why?
|
Graft Rejection | 4 | 2015 | 4426 | 0.150 |
Why?
|
Humans | 42 | 2024 | 758406 | 0.150 |
Why?
|
Liver Transplantation | 1 | 2009 | 2325 | 0.140 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2020 | 714 | 0.140 |
Why?
|
Flow Cytometry | 3 | 2014 | 5864 | 0.140 |
Why?
|
Maximum Tolerated Dose | 1 | 2019 | 876 | 0.140 |
Why?
|
Avian Proteins | 1 | 2015 | 80 | 0.130 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2010 | 4549 | 0.120 |
Why?
|
Indocyanine Green | 1 | 2017 | 236 | 0.120 |
Why?
|
Glioblastoma | 2 | 2024 | 3480 | 0.120 |
Why?
|
Deoxycytidine | 1 | 2019 | 870 | 0.120 |
Why?
|
Nanomedicine | 1 | 2017 | 288 | 0.120 |
Why?
|
Luminescent Measurements | 1 | 2016 | 341 | 0.120 |
Why?
|
Infrared Rays | 2 | 2005 | 245 | 0.110 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2019 | 1335 | 0.110 |
Why?
|
Base Pairing | 1 | 2014 | 140 | 0.110 |
Why?
|
Antineoplastic Agents | 2 | 2016 | 13591 | 0.110 |
Why?
|
Mice, Inbred NOD | 5 | 2012 | 1825 | 0.110 |
Why?
|
Cell-Free System | 1 | 2014 | 340 | 0.110 |
Why?
|
Ribonucleases | 1 | 2014 | 276 | 0.110 |
Why?
|
Drug Monitoring | 1 | 2019 | 960 | 0.100 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2009 | 8945 | 0.100 |
Why?
|
Gene Knockout Techniques | 1 | 2015 | 802 | 0.100 |
Why?
|
Positron-Emission Tomography | 1 | 2008 | 6457 | 0.100 |
Why?
|
Streptozocin | 2 | 2015 | 193 | 0.100 |
Why?
|
Tumor Cells, Cultured | 1 | 2019 | 6127 | 0.100 |
Why?
|
Dacarbazine | 1 | 2014 | 559 | 0.100 |
Why?
|
Chelating Agents | 2 | 2010 | 383 | 0.100 |
Why?
|
Biological Availability | 1 | 2012 | 390 | 0.100 |
Why?
|
Sphingomyelins | 1 | 2011 | 103 | 0.090 |
Why?
|
Salts | 1 | 2010 | 64 | 0.090 |
Why?
|
Ferrosoferric Oxide | 2 | 2009 | 348 | 0.090 |
Why?
|
Blotting, Western | 3 | 2012 | 5031 | 0.090 |
Why?
|
Mice, Transgenic | 3 | 2016 | 9518 | 0.090 |
Why?
|
DNA Repair | 1 | 2020 | 2038 | 0.090 |
Why?
|
Drug Stability | 1 | 2010 | 290 | 0.090 |
Why?
|
Fluorine Compounds | 1 | 2009 | 6 | 0.090 |
Why?
|
Transfection | 2 | 2016 | 5779 | 0.090 |
Why?
|
Particle Size | 1 | 2014 | 1641 | 0.090 |
Why?
|
Fibrin | 1 | 2012 | 505 | 0.090 |
Why?
|
Tumor Burden | 1 | 2015 | 1893 | 0.080 |
Why?
|
Major Histocompatibility Complex | 3 | 2012 | 928 | 0.080 |
Why?
|
Drug Design | 1 | 2014 | 1049 | 0.080 |
Why?
|
Curcumin | 1 | 2009 | 98 | 0.080 |
Why?
|
Immunity, Innate | 2 | 2015 | 3047 | 0.080 |
Why?
|
Image Enhancement | 2 | 2010 | 2880 | 0.080 |
Why?
|
Boron Compounds | 1 | 2009 | 180 | 0.080 |
Why?
|
Mice, SCID | 3 | 2012 | 2626 | 0.080 |
Why?
|
Surface Properties | 1 | 2010 | 1159 | 0.070 |
Why?
|
Computational Biology | 1 | 2020 | 3502 | 0.070 |
Why?
|
Papio | 1 | 2009 | 661 | 0.070 |
Why?
|
Lymphatic Metastasis | 2 | 2012 | 2943 | 0.070 |
Why?
|
Pentetic Acid | 1 | 2007 | 209 | 0.070 |
Why?
|
Mice, Inbred C57BL | 5 | 2012 | 22003 | 0.070 |
Why?
|
Prostatic Neoplasms | 1 | 2010 | 11336 | 0.070 |
Why?
|
Cell Cycle | 1 | 2015 | 2930 | 0.070 |
Why?
|
Colorectal Neoplasms | 1 | 2007 | 6852 | 0.070 |
Why?
|
Gold | 1 | 2010 | 479 | 0.070 |
Why?
|
Lymphocytes | 2 | 2015 | 2610 | 0.070 |
Why?
|
Tumor Microenvironment | 1 | 2019 | 3840 | 0.070 |
Why?
|
Gene Knockdown Techniques | 1 | 2010 | 1610 | 0.060 |
Why?
|
Antigens | 1 | 2011 | 1445 | 0.060 |
Why?
|
Molecular Probe Techniques | 1 | 2006 | 112 | 0.060 |
Why?
|
Down-Regulation | 1 | 2012 | 2904 | 0.060 |
Why?
|
Annexin A5 | 1 | 2005 | 103 | 0.060 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2012 | 936 | 0.060 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2012 | 1096 | 0.060 |
Why?
|
Cattle | 1 | 2010 | 3845 | 0.060 |
Why?
|
Cyclohexanes | 1 | 2005 | 152 | 0.060 |
Why?
|
Transplantation, Heterologous | 2 | 2012 | 2378 | 0.060 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2020 | 5249 | 0.060 |
Why?
|
Pancreatectomy | 1 | 2009 | 810 | 0.060 |
Why?
|
Neoplasm Staging | 2 | 2017 | 11152 | 0.060 |
Why?
|
Optics and Photonics | 1 | 2006 | 304 | 0.060 |
Why?
|
Liposomes | 1 | 2008 | 777 | 0.060 |
Why?
|
Breast | 1 | 2012 | 1963 | 0.060 |
Why?
|
Amino Acid Sequence | 3 | 2010 | 13447 | 0.050 |
Why?
|
Disease Progression | 2 | 2012 | 13468 | 0.050 |
Why?
|
Immunologic Memory | 1 | 2010 | 1353 | 0.050 |
Why?
|
Green Fluorescent Proteins | 1 | 2008 | 2057 | 0.050 |
Why?
|
Coloring Agents | 1 | 2005 | 560 | 0.050 |
Why?
|
Magnetic Resonance Angiography | 1 | 2009 | 1431 | 0.050 |
Why?
|
Molecular Sequence Data | 3 | 2010 | 17617 | 0.050 |
Why?
|
Genomics | 1 | 2018 | 5790 | 0.050 |
Why?
|
Environmental Monitoring | 1 | 2009 | 1445 | 0.050 |
Why?
|
Models, Animal | 1 | 2008 | 2112 | 0.050 |
Why?
|
Autoimmunity | 1 | 2010 | 1358 | 0.050 |
Why?
|
Angiography | 1 | 2007 | 1599 | 0.050 |
Why?
|
Immunohistochemistry | 2 | 2012 | 11070 | 0.050 |
Why?
|
Combined Modality Therapy | 1 | 2013 | 8530 | 0.050 |
Why?
|
Fluorouracil | 1 | 2006 | 1631 | 0.050 |
Why?
|
Microscopy, Confocal | 4 | 2008 | 1969 | 0.040 |
Why?
|
Blood-Brain Barrier | 1 | 2005 | 1018 | 0.040 |
Why?
|
Radiopharmaceuticals | 1 | 2008 | 2634 | 0.040 |
Why?
|
Water | 1 | 2005 | 1402 | 0.040 |
Why?
|
Antibodies, Monoclonal | 3 | 2011 | 9160 | 0.040 |
Why?
|
Rats | 2 | 2011 | 23679 | 0.040 |
Why?
|
Pyridines | 1 | 2010 | 2859 | 0.040 |
Why?
|
Tissue Distribution | 2 | 2017 | 2262 | 0.040 |
Why?
|
Antigens, Neoplasm | 1 | 2006 | 1997 | 0.040 |
Why?
|
Insulin | 2 | 2011 | 6578 | 0.040 |
Why?
|
Blood Glucose | 2 | 2015 | 6346 | 0.040 |
Why?
|
Reproducibility of Results | 3 | 2016 | 20055 | 0.040 |
Why?
|
Graft Survival | 1 | 2008 | 3794 | 0.040 |
Why?
|
Phenotype | 1 | 2015 | 16534 | 0.040 |
Why?
|
Autoimmune Diseases | 1 | 2009 | 2244 | 0.040 |
Why?
|
Indoles | 1 | 2005 | 1828 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2003 | 1788 | 0.030 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2010 | 3071 | 0.030 |
Why?
|
Amyloid beta-Peptides | 1 | 2009 | 3826 | 0.030 |
Why?
|
Glycosylation | 2 | 2012 | 1095 | 0.030 |
Why?
|
Papio hamadryas | 1 | 2015 | 31 | 0.030 |
Why?
|
Early Detection of Cancer | 1 | 2010 | 3211 | 0.030 |
Why?
|
Haplotypes | 1 | 2002 | 2764 | 0.030 |
Why?
|
Scorpion Venoms | 1 | 2014 | 29 | 0.030 |
Why?
|
Glioma | 1 | 2010 | 3418 | 0.030 |
Why?
|
O(6)-Methylguanine-DNA Methyltransferase | 1 | 2014 | 83 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 4567 | 0.030 |
Why?
|
Kidney | 1 | 2009 | 7016 | 0.030 |
Why?
|
Treatment Outcome | 3 | 2016 | 64378 | 0.030 |
Why?
|
Peptide Fragments | 1 | 2006 | 5098 | 0.030 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2009 | 12075 | 0.030 |
Why?
|
Molecular Structure | 2 | 2009 | 1866 | 0.030 |
Why?
|
Weight Gain | 1 | 2003 | 2346 | 0.030 |
Why?
|
Sialyltransferases | 1 | 2012 | 81 | 0.030 |
Why?
|
Neuraminidase | 1 | 2012 | 199 | 0.030 |
Why?
|
N-Acetylneuraminic Acid | 1 | 2012 | 173 | 0.020 |
Why?
|
Fumonisins | 1 | 2011 | 10 | 0.020 |
Why?
|
Chromatography | 1 | 2011 | 189 | 0.020 |
Why?
|
Toxins, Biological | 1 | 2011 | 60 | 0.020 |
Why?
|
beta-Cyclodextrins | 1 | 2011 | 68 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2011 | 3801 | 0.020 |
Why?
|
Cell Line | 3 | 2011 | 15591 | 0.020 |
Why?
|
Tissue Array Analysis | 1 | 2012 | 551 | 0.020 |
Why?
|
Neurons | 1 | 2010 | 9416 | 0.020 |
Why?
|
Gene Expression Regulation | 1 | 2008 | 11892 | 0.020 |
Why?
|
Glucose-6-Phosphatase | 1 | 2010 | 72 | 0.020 |
Why?
|
Organ Size | 1 | 2015 | 2252 | 0.020 |
Why?
|
Diabetes Mellitus | 1 | 2008 | 5816 | 0.020 |
Why?
|
Perforin | 1 | 2010 | 167 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2012 | 1705 | 0.020 |
Why?
|
Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2010 | 117 | 0.020 |
Why?
|
Injections, Intralesional | 1 | 2010 | 278 | 0.020 |
Why?
|
Genotype | 1 | 2003 | 12945 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2017 | 14641 | 0.020 |
Why?
|
Caspase 3 | 1 | 2011 | 728 | 0.020 |
Why?
|
Cell Membrane Permeability | 1 | 2010 | 575 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2012 | 1177 | 0.020 |
Why?
|
Prognosis | 2 | 2012 | 29557 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 2015 | 4809 | 0.020 |
Why?
|
Erythrocytes | 1 | 2015 | 2413 | 0.020 |
Why?
|
Male | 4 | 2016 | 358747 | 0.020 |
Why?
|
Histocytochemistry | 1 | 2006 | 700 | 0.020 |
Why?
|
beta-Alanine | 1 | 2005 | 81 | 0.020 |
Why?
|
Acute Disease | 1 | 2015 | 7225 | 0.010 |
Why?
|
Protein Processing, Post-Translational | 1 | 2012 | 1972 | 0.010 |
Why?
|
Antigen Presentation | 1 | 2010 | 1254 | 0.010 |
Why?
|
Cell Transplantation | 1 | 2005 | 472 | 0.010 |
Why?
|
Solubility | 1 | 2005 | 1088 | 0.010 |
Why?
|
Brain | 1 | 2010 | 26947 | 0.010 |
Why?
|
Spectrometry, Fluorescence | 1 | 2005 | 681 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2015 | 4158 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 2005 | 2557 | 0.010 |
Why?
|
Astrocytes | 1 | 2010 | 1337 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2012 | 5199 | 0.010 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2005 | 1539 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2010 | 3156 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2010 | 2416 | 0.010 |
Why?
|
Polymers | 1 | 2008 | 1616 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2011 | 3709 | 0.010 |
Why?
|
Lipids | 1 | 2011 | 3326 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2002 | 17768 | 0.010 |
Why?
|
Time Factors | 2 | 2015 | 39872 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2015 | 15225 | 0.010 |
Why?
|
Protein Binding | 1 | 2011 | 9311 | 0.010 |
Why?
|
Base Sequence | 1 | 2010 | 12436 | 0.010 |
Why?
|
Survival Rate | 1 | 2012 | 12721 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2012 | 12759 | 0.010 |
Why?
|
Fatty Acids | 1 | 2005 | 1803 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2010 | 3533 | 0.010 |
Why?
|
Phantoms, Imaging | 1 | 2005 | 2509 | 0.010 |
Why?
|
Proteins | 1 | 2010 | 6026 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2010 | 18940 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2010 | 11471 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2012 | 39059 | 0.010 |
Why?
|